Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

ne 30, 2007, and

$12.6 million as of September 30, 2006. Following the third quarter of

2007, MiddleBrook entered into an agreement with Deerfield Management

resulting in the addition of $7.5 million of gross proceeds to the

Company. MiddleBrook used a portion of the proceeds from this

financing to retire the Company's outstanding credit facility of

approximately $4.6 million.

-- Deferred product revenue. Due to the Company's corporate name change on

June 28, 2007, inventories of products on hand at that time were

required to be relabeled. At the end of the second quarter 2007, the

Company offered a one-time incentive to wholesalers to purchase up to a

two-month supply of Keflex products, to avoid stock-out situations at

wholesalers during the relabeling process. This incentive offer

resulted in orders of approximately $2.0 million of gross sales.

Revenue recognition for this transaction was deferred as of June 30,

2007, and the Company recognized net revenue of $1.8 million during the

third quarter of 2007, the period when the related product was sold by

the wholesalers.

FINANCIAL GUIDANCE AND FUTURE CASH REQUIREMENTS

As previously announced, in order to preserve corporate resources, the Company has undertaken cost reductions during 2007, including personnel reductions, postponement of PULSYS clinical development programs other than Amoxicillin PULSYS for adults, and elimination of other discretionary spending.

Total revenue for 2007 is expected to be approximately $10 million to $12 million, resulting from Keflex product sales. Total cash used in operating activities and capital expenditures in 2007 is estimated to be between $33 and $35 million.

Assuming the Company's expectations for continued sales of its Keflex 750 mg product and anticipated level of R&D spending and other obligations, M
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... The automated external defibrillator market ... categories - semi-automated and fully automated defibrillators. Based ... categories, namely, hospitals, pre-hospital, public access, alternate care, ... Automated external defibrillators play an important role in ... Considering the life-saving potential of AEDs, legislations requiring ...
(Date:5/20/2013)... new healthcare bill proposes to have major ramifications in ... all the conditions were to be implemented or have ... 2014 to show anything. , According to Health ... forward to implement the health care law and establishing ... and West Virginia. HHS will continue to provide the ...
(Date:5/20/2013)... 20, 2013 Eben Pagan's ... the public creating a frenzy among business owners ... elite business training. WealthSpringMarketing.com's Tiffany Hendricks has published ... an exclusive bonus. , "Eben Pagan is a ... training to individuals serious about success," reports Hendricks. ...
(Date:5/20/2013)... According to a May 6, 2013 CBS ... Salons,” tanning salons in the US may soon ... Administration wants to see cancer warnings on indoor tanning ... of eighteen for the use of indoor tanning and sun ... has become increasingly common over the last few decades (Go ...
(Date:5/20/2013)... Lake City, UT (PRWEB) May 20, 2013 ... named one of Select Health’s Select 25 winners ... receive $2500 from Select Health. Know Greater Heroes is a ... local elementary schools to teach children how to eat right, ... student athletes participate in the Know Greater Heroes program each ...
Breaking Medicine News(10 mins):Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Review of Health Bill Impact in 2014 2Health News:Review of Health Bill Impact in 2014 3Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3
... Hologic, Inc. (Nasdaq: HOLX ) today announced that Glenn ... Global Healthcare Unplugged Conference in New York City on Tuesday, September ... Interested parties are invited to listen to a live audio ... company,s website at www.hologic.com/investor . An archive of ...
... , , , ... (Nasdaq: ZIXI ), the leader in email encryption services, today ... is a two-year extension of Humana,s original agreement which has now spanned ... ZixCorp licenses bringing the total to 36,000. , , ...
... in the September 2009 issue of the Journal of ... life prior to treatment can help predict the overall survival ... For those with advanced stage NSCLC, the median overall ... of patients surviving past the one year mark. To better ...
... study, approximately 20% of U.S. soldiers returning from Iraq ... substantial number with post-traumatic stress disorder (PTSD), and the ... unacceptable to Army commanders and the soldiers, families. ... doctors will now be able to forecast a soldier,s ...
... discounts, special promotions lead to greater alcohol consumption, study shows ... college bars lead to more intoxicated students and more health ... news that college students drink and the results can be ... the impact of drink discounts at college bars and found ...
... , , , WASHINGTON, Sept. ... flu, or H1N1 outbreak, in a recent article . , ... of the Mexican government in the fields of public awareness, rapid ... , The article noted "Mexico,s most effective action ...
Cached Medicine News:Health News:Zix Corporation and Humana Renew and Expand Exclusive Agreement 2Health News:Keeping the suicidal soldier alive 2Health News:College Students Get More Drunk When Drinks Are Cheap 2
(Date:5/20/2013)... -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that ... presented updated Phase I data from its spinal cord-derived ... of amyotrophic lateral sclerosis (ALS or Lou ... medical symposium in Bucharest, Romania , ... in Stem Cell Therapy," Dr. Feldman outlined the design ...
(Date:5/20/2013)... CHICAGO, Ill. , May 20, 2013 /PRNewswire/ ... the initiation of a Phase 3 clinical study ... to assess the effects of the investigational compound ... progression of kidney disease in patients with stage ... type 2 diabetes.  SONAR is a large, multinational, ...
(Date:5/20/2013)... , May 20, 2013 With herbal medicines ... available from the U.S. Pharmacopeial Convention (USP) will provide ... of the herbal ingredients used in these products. Today, ... in the new Herbal Medicines Compendium ( ... at hmc.usp.org . HMC ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: